Judy E. Garber

67.9k citations

389 papers · 29.0k indexed · 11 hit papers · h-index 86

Impact in

Cancer Research top 0.05%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
Reproductive Medicine top 0.05%
- Ovarian cancer diagnosis and treatment

Papers in

Cancer Research 124
- Cancer Genomics and Diagnostics 84
- Breast Cancer Treatment Studies 38
Genetics 211
- BRCA gene mutations in cancer 192

Co-authors: Richard D. Kolodner Kenneth Offit Nadine Tung Janice Zeman N G Copeland Richard Fishel Michael Kane Nancy A. Jenkins
Journals: Journal of Clinical Oncology (86 papers)Breast Cancer Research and Treatment (18 papers)Cancer Research (14 papers)Cancer (13 papers)JCO Precision Oncology (12 papers)
Partner nations: United States Israel United Kingdom

In The Last Decade

Judy E. Garber

371 papers receiving 28.2k citations

Hit Papers

11 papers align trajectories log scale

Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer 2016 · 451 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2016 Oncotarget
2016 Journal of Clinical Oncology
2011 New England Journal of Medicine
2010 The Lancet
2006 The Journal of Pathology
2006 The American Journal of Surgical Pathology
2004 Journal of Clinical Oncology
2002 New England Journal of Medicine
1999 Science
1997 New England Journal of Medicine
1993 Cell

Peers

Countries citing papers authored by Judy E. Garber

Since Specialization

Citations

This map shows the geographic impact of Judy E. Garber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judy E. Garber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judy E. Garber more than expected).

Fields of papers citing papers by Judy E. Garber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judy E. Garber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judy E. Garber. The network helps show where Judy E. Garber may publish in the future.

Co-authors

The 25 scholars most cited alongside Judy E. Garber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Judy E. Garber Line = papers co-authored together Judy E. Garber links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	P091: Variants at variance: An assessment of discordant classifications and phenotypes among TP53 variants from the international LiFT UP study SHILAP Revista de lepidopterología ·Hisato Hino, Bita Nehoray, 이은지, 王胜煌, Megan N. Frone, Christopher I. Amos, Stephen B. Gruber, Judy E. Garber	2024	1
2	Automated prediction of response to neoadjuvant chemotherapy from digitized H&E slides of pre-treatment core needle biopsies in germline BRCA carriers with HER2-negative breast cancer (TBCRC 031). Journal of Clinical Oncology ·Nadine Tung, Stuart J. Schnitt, Judy E. Garber, Gaucher Anne, Tathagata Dasgupta, Cordula Wiest	2024	0
3	TP53-associated early breast cancer: new observations from a large cohort JNCI Journal of the National Cancer Institute ·Renata Lazari Sandoval, Michele Bottosso, Tianyu Li, А. В. Сушкевич, Brittany Bychkovsky, Benjamin Verret, Alessandra Gennari, 이은지, Maria Isabel Achatz, Olivier Caron, 山本明夫, Catherine Noguès, Philisiwe Ndlovu, Cristina Fortuño, Amanda B. Spurdle, Nabihah Tayob, Fabrice André, Judy E. Garber	2024	6
4	Pathogenic variants among females with breast cancer and a non-breast cancer reveal opportunities for cancer interception Breast Cancer Research and Treatment ·Brittany Bychkovsky, Min‐Tzu Lo, Amal Yussuf, Carolyn Horton, J. F. de A. Nogueira, Holly LaDuca, Judy E. Garber, Rochelle Scheib, Huma Q. Rana	2023	0
5	Identification of BRCA1/2 mutation female carriers using circulating microRNA profiles Nature Communications ·Kevin M. Elias, H. Seifert, Konrad Stawiski, Zuzanna Nowicka, Rong fang Bie -, M. Al-Rashdi, Charles N. Landen, Jan Lubiński, Asima Mukhopadhyay, W. Margoulis, Denise C. Connolly, Heather Symecko, Susan M. Domchek, Judy E. Garber, Panagiotis A. Konstantinopoulos, Wojciech Fendler, Dipanjan Chowdhury	2023	11
6	Germline Testing Data Validate Inferences of Mutational Status for Variants Detected From Tumor-Only Sequencing JCO Precision Oncology ·Pengfei Sun, Israel Gomy, Howard Elbaum, Alexander Gusev, Bruce E. Johnson, Neal I. Lindeman, Laura E. MacConaill, Shridar Ganesan, Judy E. Garber, Hossein Khiabanian	2021	9
7	The Influence of Vitamin D on Mammographic Density: Results from CALGB 70806 (Alliance) a Randomized Clinical Trial Cancer Prevention Research ·Marie Wood, Heshan Liu, G Haza, David Zahrieh, Danielle Arribet-Deroin, Sin‐Ho Jung, Patricia J. Zekan, Margaret Kemeny, Johnny Alexander, Hyeyoon EOM, Gary Unzeitig, Candace S. Johnson, Judy E. Garber, James R. Marshall, Isabelle Bedrosian	2021	6
8	Comprehensive Breast Cancer Risk Assessment for CHEK2 and ATM Pathogenic Variant Carriers Incorporating a Polygenic Risk Score and the Tyrer-Cuzick Model JCO Precision Oncology ·Shannon Gallagher, Elisha Hughes, Allison W. Kurian, Susan M. Domchek, Judy E. Garber, Christofpher Halldén, Brian Morris, Isabel Ruppén Cañás, Stephanie Meek, Eric T. Rosenthal, Benjamin B. Roa, Thomas P. Slavin, Susanne Wagner, Jeffrey N. Weitzel, Alexander Gutin, Jerry S. Lanchbury, Mark E. Robson	2021	14
9	Randomized Phase IIB Trial of the Lignan Secoisolariciresinol Diglucoside in Premenopausal Women at Increased Risk for Development of Breast Cancer Cancer Prevention Research ·Carol J. Fabian, Seema A. Khan, Judy E. Garber, William C. Dooley, Xuhui Lee, Jennifer R. Klemp, О. Н. Кузьмина, Rehana Meru, Zaynab Mahmud al-Khudayri, Carola M. Zalles, Trina Metheny, Teresa A. Phillips, Jinxiang Hu, Devin C. Koestler, Prabhakar Chalise, Nanda Kumar Yellapu, T. Zhang, Brian K. Petroff, Stephen D. Hursting, Bruce F. Kimler	2020	19
10	Use of Endocrine Therapy for Breast Cancer Risk Reduction: ASCO Clinical Practice Guideline Update Journal of Clinical Oncology ·Kala Visvanathan, Carol J. Fabian, Elissa Bantug, Abenaa M. Brewster, Nancy E. Davidson, Andrea DeCensi, Justin D. Floyd, Judy E. Garber, Erin Hofstatter, Seema A. Khan, Maria C. Katapodi, Sandhya Pruthi, Keith Marais, Carolyn D. Runowicz, Mark R. Somerfield	2019	117
11	Discrimination of Germline EGFR T790M Mutations in Plasma Cell-Free DNA Allows Study of Prevalence Across 31,414 Cancer Patients Clinical Cancer Research ·Yuebi Hu, Ryan S. Alden, Justin I. Odegaard, Stephen R. Fairclough, A. Woodard, Jennifer Heng, Nora Feeney, Rebecca J. Nagy, P. Soriano, Bryan C. Ulrich, Arisa Nagao, Richard B. Lanman, Judy E. Garber, Cloud P. Paweletz, Geoffrey R. Oxnard	2017	63
12	Evolutionary Pathways in BRCA1-Associated Breast Tumors Cancer Discovery ·Filipe Correia Martins, Subhajyoti De, Vanessa Almendro, Mithat Gönen, So Yeon Park, Joanne L. Blum, Arkadiusz Padrak, GLP Fernandes, Stuart J. Schnitt, Nadine Tung, Judy E. Garber, Eteia Dassinakis Santos, Franziska Michor, Kornélia Polyák	2012	95
13	Telomeric Allelic Imbalance Indicates Defective DNA Repair and Sensitivity to DNA-Damaging Agents Cancer Discovery ·Nicolai J. Birkbak, Zhigang C. Wang, Ji-Young Kim, Aron C. Eklund, Qiyuan Li, Ruiyang Tian, Christian Bowman-Colin, Yang Li, April Greene-Colozzi, J. Dirk Iglehart, Nadine Tung, Paula D. Ryan, Judy E. Garber, Daniel P. Silver, Zoltán Szállási, Andrea L. Richardson	2012	412
14	Multimodal Assessment of Protein Functional Deficiency Supports Pathogenicity of BRCA1 p.V1688del Cancer Research ·Arcangela De Nicolo, Emilio Parisini, Quan Zhong, Maurizia Dalla Palma, Rosemary Howard Gill, Susan M. Domchek, Katherine L. Nathanson, Maria A. Caligo, Marc Vidal, Michael E. Cusick, Judy E. Garber	2009	14
15	Prevalence and Functional Analysis of Sequence Variants in the ATR Checkpoint Mediator Claspin Molecular Cancer Research ·Jianmin Zhang, Young‐Han Song, Brian W. Brannigan, Doke C.R. Wahrer, Taryn A. Schiripo, Patricia L. Harris, Sara M. Haserlat, Lindsey E. Ulkus, Kristen Shannon, Judy E. Garber, Matthew L. Freedman, Brian E. Henderson, Lee Zou, Dennis C. Sgroi, Daniel A. Haber, Daphne W. Bell	2009	12
16	Risk-Reducing Salpingo-Oophorectomy for the Prevention of BRCA1- and BRCA2-Associated Breast and Gynecologic Cancer: A Multicenter, Prospective Study Journal of Clinical Oncology ·Noah D. Kauff, Susan M. Domchek, Tara M. Friebel, Mark E. Robson, Johanna Lee, Judy E. Garber, Claudine Isaacs, D. Gareth Evans, Henry T. Lynch, Rosalind A. Eeles, Susan L. Neuhausen, Mary B. Daly, Ellen Matloff, Joanne L. Blum, Paul Sabbatini, Richard R. Barakat, Clifford A. Hudis, Larry Norton, Kenneth Offit, Timothy R. Rebbeck	2008	381
17	RASSF1A Polymorphism A133S Is Associated with Early Onset Breast Cancer in BRCA1/2 Mutation Carriers Cancer Research ·Boning Gao, Xian‐Jin Xie, Russel J. Owen, David S. Shames, Dinda Kartika Nugraheni, Cheryl Lewis, Aihua Bian, Bifeng Zhang, Olufunmilayo I. Olopade, Judy E. Garber, David Euhus, Gail E. Tomlinson, John D. Minna	2008	40
18	Information Needs of Mothers Regarding Communicating BRCA1/2 Cancer Genetic Test Results to Their Children Genetic Testing ·Kenneth P. Tercyak, Beth N. Peshkin, Tiffani A. DeMarco, Andrea Farkas Patenaude, Katherine A. Schneider, Judy E. Garber, Heiðdís Valdimarsdóttir, Marc D. Schwartz	2007	40
19	Frequent Met Oncogene Amplification in a Brca1/Trp53 Mouse Model of Mammary Tumorigenesis Cancer Research ·Gromoslaw A. Smolen, Beth Muir, Gayatry Mohapatra, Anne Barmettler, Woo Jae Kim, Miguel N. Rivera, Sara M. Haserlat, Ross A. Okimoto, Eunice L. Kwak, Sonika Dahiya, Judy E. Garber, Daphne W. Bell, Dennis C. Sgroi, Lynda Chin, Chu‐Xia Deng, Daniel A. Haber	2006	32
20	Accuracy of Cancer Family Histories: Comparison of Two Breast Cancer Syndromes Genetic Testing ·Katherine A. Schneider, L. Digianni, Andrea Farkas Patenaude, Neil Klar, Jill E. Stopfer, (unknown), Frederick P. Li, Barbara Weber, Judy E. Garber	2004	35

About Judy E. Garber

Judy E. Garber is a scholar working on Cancer Research, Genetics, Oncology, Pathology and Forensic Medicine and Reproductive Medicine, having authored 389 papers that have together received 29.0k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (192 papers), Cancer Genomics and Diagnostics (84 papers), DNA Repair Mechanisms (48 papers), Genetic factors in colorectal cancer (48 papers), Cancer-related Molecular Pathways (43 papers), Breast Cancer Treatment Studies (38 papers), PARP inhibition in cancer therapy (38 papers) and Ovarian cancer diagnosis and treatment (23 papers). The work is most often cited by research in Cancer Research (8.5k citations), Reproductive Medicine (4.1k citations), Genetics (13.0k citations), Oncology (11.0k citations) and Pathology and Forensic Medicine (6.4k citations). Judy E. Garber has collaborated with scholars based in United States, Israel and United Kingdom. Frequent co-authors include Richard D. Kolodner, Kenneth Offit, Nadine Tung, Janice Zeman, N G Copeland, Richard Fishel, Michael Kane, Nancy A. Jenkins, Mary Kay Lescoe and Manchanahalli R. Satyanarayana Rao. Their work appears in journals such as Journal of Clinical Oncology, Breast Cancer Research and Treatment, Cancer Research, Cancer and JCO Precision Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact